US Medicare Creates New Code For Theranica’s Headache Device
Medicare beneficiaries suffering from migraines will soon have access to an innovate drug-free treatment at the touch of their smartphones.
You may also be interested in...
The FDA granted a de novo clearance to Theranica’s Nerivio Migra smartphone-controlled remote electrical neuromodulation device for acute treatment of migraine headaches.
The US FDA has published a draft guidance outlining its current thinking on ethical considerations for clinical trials of medical products, including devices, that enroll children.
The American Telehealth Association has created a coalition with the mission of ensuring patients have a voice in the future of telehealth.